Cargando…
VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
Vascular endothelial growth factor (VEGF) pathway targeting agents have been combined with other anticancer drugs, leading to improved efficacy in carcinoma of the cervix, stomach, lung, colon and rectum, ovary, and breast. Vessel normalization induced by VEGF pathway targeting agents influences tum...
Autores principales: | Arjaans, Marlous, Schröder, Carolina P., Oosting, Sjoukje F., Dafni, Urania, Kleibeuker, Josée E., de Vries, Elisabeth G.E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008282/ https://www.ncbi.nlm.nih.gov/pubmed/26789111 http://dx.doi.org/10.18632/oncotarget.6918 |
Ejemplares similares
-
Human stromal cells are required for an anti-breast cancer effect of zoledronic acid
por: Nienhuis, Hilde H., et al.
Publicado: (2015) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
Bench and Bedside
por: Schmidt, Christian
Publicado: (2002) -
Oncolytic Virotherapy: From Bench to Bedside
por: Yang, Ludi, et al.
Publicado: (2021) -
From bench to bedside
por: Verdant, Colin L
Publicado: (2012)